Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership302,280 shares
Latest Disclosed Value $ 8,980,739
Jane Street Group, Llc ownership in TVTX / Travere Therapeutics, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 302,280 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $8,980,739 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 392,273 shares of Travere Therapeutics, Inc.. This represents a change in shares of -22.94% during the quarter. The current value of the position is $13,663,056 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (TVTX) in the form of stock options. The firm currently holds call options representing 191,600 of underlying shares valued at $5,692,436 USD and put options representing 48,500 of underlying shares valued at $1,440,935 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TVTX / Travere Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 302,280 -89,993 -22.94 8,981 -40.09 0.0006
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 392,273 392,273 14,989 0.0023
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -72,018 -100.00 0 -100.00
2025-05-19 2025-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 72,018 6,328 9.63 1,291 12.76 0.0003
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 72,018 6,328 1,291 0.0003
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 65,690 -245,570 -78.90 1,144 -73.73 0.0002
2024-11-15 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 311,260 -98,597 -24.06 4,355 29.24 0.0010
2024-08-15 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 409,857 20,649 5.31 3,369 12.30 0.0008
2024-05-16 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 389,208 137,108 54.39 3,001 32.39 0.0006
2024-02-15 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 252,100 84,554 50.47 2,266 51.37 0.0006
2023-11-15 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 167,546 99,560 146.44 1,498 43.39 0.0005
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 67,986 -173,258 -71.82 1,044 -80.76 0.0004
2023-05-16 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 241,244 241,244 5,426 0.0022
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 0 -27,994 -100.00 0 -100.00
2022-08-16 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 27,994 27,994 678 0.0003
2022-05-17 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 0 -10,104 -100.00 0 -100.00
2022-02-15 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 10,104 -314 -3.01 314 24.11 0.0001
2021-11-16 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 10,418 -58,526 -84.89 253 -74.85 0.0001
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 68,944 59,335 617.49 1,006 319.17 0.0004
2021-05-18 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 9,609 -9,568 -49.89 240 -54.11 0.0001
2021-02-17 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,177 1,532 8.68 523 60.43 0.0003
2020-11-17 2020-09-30 13F RETROPHIN COM 761299106 17,645 17,645 -7.99 326 -37.67 0.0002
2020-02-14 2019-12-31 13F RETROPHIN COM 761299106 0 -21,016 -100.00 0 -100.00
2019-11-14 2019-09-30 13F RETROPHIN COM 761299106 21,016 21,016 244 0.0004
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 0 -79,920 -100.00 0 -100.00
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 79,920 79,920 2,296 0.0045
2016-08-15 2016-06-30 13F RETROPHIN COM 761299106 0 -13,381 -100.00 0 -100.00
2016-05-17 2016-03-31 13F RETROPHIN COM 761299106 13,381 13,381 0.00 183 0.0010
2015-11-16 2015-09-30 13F RETROPHIN COM 761299106 0 -17,986 -100.00 0 -100.00
2015-08-14 2015-06-30 13F RETROPHIN COM 761299106 17,986 6,421 55.52 596 115.16 0.0039
2015-05-12 2015-03-31 13F/A-1 RETROPHIN COM 761299106 11,565 11,565 -35.70 277 -53.52 0.0021
2015-02-17 2014-12-31 13F RETROPHIN COM 761299106 0 -10,280 -100.00 0 -100.00
2014-11-14 2014-09-30 13F RETROPHIN COM 761299106 10,280 10,280 93 0.0009
2014-08-14 2014-06-30 13F RETROPHIN COM 761299106 0 -119,356 -100.00 0 -100.00
2014-05-15 2014-03-31 13F RETROPHIN COM 761299106 119,356 119,356 2,531 0.0280
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F TRAVERE THERAPEUTICS COM Call 191,600 -25.39 5,692 -41.99 n/a n/a n/a
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM Call 256,800 -20.30 9,812 27.43 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Call 322,200 -33.73 7,701 7.02 n/a n/a n/a
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM Call 486,200 137.17 7,196 95.89 n/a n/a n/a
2025-05-19 2025-03-31 13F/A TRAVERE THERAPEUTICS COM Call 205,000 -21.85 3,674 -19.61 n/a n/a n/a
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM Call 205,000 3,674 n/a n/a n/a
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM Call 262,300 173.51 4,569 240.72 n/a n/a n/a
2024-11-15 2024-09-30 13F TRAVERE THERAPEUTICS COM Call 95,900 831.07 1,342 1,496.43 n/a n/a n/a
2024-08-15 2024-06-30 13F TRAVERE THERAPEUTICS COM Call 10,300 -1.90 85 5.00 n/a n/a n/a
2024-05-16 2024-03-31 13F TRAVERE THERAPEUTICS COM Call 10,500 -75.75 81 -79.43 n/a n/a n/a
2024-02-15 2023-12-31 13F TRAVERE THERAPEUTICS COM Call 43,300 -24.30 389 -23.87 n/a n/a n/a
2023-11-15 2023-09-30 13F TRAVERE THERAPEUTICS COM Call 57,200 125.20 511 31.03 n/a n/a n/a
2023-08-14 2023-06-30 13F TRAVERE THERAPEUTICS COM Call 25,400 390 n/a n/a n/a
2022-11-14 2022-09-30 13F TRAVERE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-16 2022-06-30 13F TRAVERE THERAPEUTICS COM Call 15,600 -62.68 378 -64.90 n/a n/a n/a
2022-05-17 2022-03-31 13F TRAVERE THERAPEUTICS COM Call 41,800 89.14 1,077 57.00 n/a n/a n/a
2022-02-15 2021-12-31 13F TRAVERE THERAPEUTICS COM Call 22,100 686 n/a n/a n/a
2015-11-16 2015-09-30 13F RETROPHIN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F RETROPHIN COM Call 9,500 315 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F TRAVERE THERAPEUTICS COM Put 48,500 18.00 1,441 -8.28 n/a n/a n/a
2026-02-12 2025-12-31 13F TRAVERE THERAPEUTICS COM Put 41,100 -40.35 1,570 -4.62 n/a n/a n/a
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM Put 68,900 1,647 n/a n/a n/a
2025-08-14 2025-06-30 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-19 2025-03-31 13F/A TRAVERE THERAPEUTICS COM Put 413,700 -24.31 7,414 -22.14 n/a n/a n/a
2025-05-14 2025-03-31 13F TRAVERE THERAPEUTICS COM Put 413,700 7,414 n/a n/a n/a
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM Put 546,600 -1.28 9,522 22.92 n/a n/a n/a
2024-11-15 2024-09-30 13F TRAVERE THERAPEUTICS COM Put 553,700 7,746 n/a n/a n/a
2022-08-16 2022-06-30 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-17 2022-03-31 13F TRAVERE THERAPEUTICS COM Put 9,100 40.00 235 16.34 n/a n/a n/a
2022-02-15 2021-12-31 13F TRAVERE THERAPEUTICS COM Put 6,500 202 n/a n/a n/a
2021-11-16 2021-09-30 13F TRAVERE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F TRAVERE THERAPEUTICS COM Put 13,800 201 n/a n/a n/a
2020-02-14 2019-12-31 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F RETROPHIN COM Put 10,400 121 n/a n/a n/a
2015-11-16 2015-09-30 13F RETROPHIN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F RETROPHIN COM Put 17,900 593 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.